Results for untargeted MS search on m/z: (+/-) mode
Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
---|---|---|---|---|---|---|---|---|---|---|
AN001156 | 57.0583 | 1.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 69.0584 | 0.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 71.0742 | 0.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 83.9530 | 0.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 85.9858 | 0.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 100.0012 | 0.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 100.0016 | 0.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 102.0473 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 103.0460 | 1.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 103.0997 | 22.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 109.0015 | 0.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 112.1000 | 0.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 113.0831 | 4.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 113.9815 | 0.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | CREATININE-(GUANIDINO-13C) [ISTD] (CAS# ); (2M+H)+ | 114.0616 | 0.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | 115.0636 | 0.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 117.0794 | 0.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 118.0424 | 1.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 119.0586 | 0.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 119.0737 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 121.0635 | 0.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 122.0379 | 1.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 122.0483 | 1.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 123.0329 | 1.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 123.0684 | 1.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 124.0526 | 2.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 124.9791 | 0.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 125.0847 | 6.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 126.0658 | 2.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 129.0429 | 0.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 129.0577 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 129.0791 | 0.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 131.0698 | 0.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 131.0739 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 131.0949 | 1.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 132.0252 | 1.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 134.0942 | 4.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 135.0548 | 3.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 135.0682 | 1.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 136.0389 | 1.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 136.0392 | 1.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 136.0638 | 0.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 137.0584 | 5.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 137.0843 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 138.0454 | 5.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | L-[15N]ANTHRANILIC ACID [ISTD] (CAS# ); (M+H)+ | 138.0460 | 5.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | 140.0052 | 1.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 140.9516 | 1.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 141.1156 | 1.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 142.1106 | 3.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 143.0727 | 3.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 143.0945 | 0.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 144.0243 | 2.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 145.0526 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 145.1098 | 3.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 145.1577 | 0.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 146.0519 | 3.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 146.9961 | 0.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 147.0538 | 0.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 148.0528 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 149.0516 | 1.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 150.0891 | 2.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 150.1038 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 151.0497 | 1.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 151.0636 | 3.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 151.0993 | 3.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 152.0578 | 1.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1-(4-HYDROXYPHENYL)-2-AMINOETHANOL (CAS# 104-14-3); (M+H)+[-H2O] | 153.0781 | 0.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | 153.0788 | 1.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 153.1143 | 1.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 154.0970 | 6.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 155.1310 | 1.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 156.0766 | 3.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 156.0788 | 3.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 157.1097 | 1.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 157.1466 | 15.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 158.0845 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 159.0687 | 1.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 159.1258 | 0.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 161.0147 | 1.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 161.0515 | 1.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 161.1051 | 0.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | PROCOLLAGEN 5-HYDROXY-L-LYSINE (CAS# 1190-94-9); (M+NA)+ | 162.1000 | 0.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | PROCOLLAGEN 5-HYDROXY-L-LYSINE (CAS# 1190-94-9); (M+H)+ | 162.1001 | 0.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | 162.1255 | 10.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 164.0477 | 1.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 165.0791 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 166.0495 | 2.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 166.0972 | 9.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 167.0552 | 1.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 167.1300 | 3.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 168.0288 | 1.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 168.0520 | 0.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 168.0783 | 5.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 168.0894 | 2.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 168.1128 | 8.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 169.0353 | 0.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 169.0527 | 3.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 169.0741 | 1.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 169.1098 | 1.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 169.1465 | 2.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 170.0905 | 6.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 171.1256 | 4.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 172.0860 | 12.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 173.0691 | 5.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 173.1415 | 1.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 174.0270 | 4.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 175.0688 | 3.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 175.9781 | 0.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 176.0982 | 1.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | L-ARGININE-(GUANIDINEIMINO-15N2) [ISTD] (CAS# ); (M+H)+ | 176.1063 | 0.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | 178.0416 | 1.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 178.0971 | 10.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 179.0590 | 4.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | D-MANNOSAMINE (CAS# 14307-02-9); (M+H)+[-H2O] | 179.0781 | 0.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | 180.0647 | 3.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 180.1257 | 8.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 181.0738 | 1.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 181.1459 | 4.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 181.9552 | 0.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 182.0915 | 4.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 182.1278 | 13.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 183.0534 | 1.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 184.0249 | 0.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 184.0354 | 3.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 184.1076 | 10.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 184.1213 | 3.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 185.0122 | 0.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 185.1041 | 1.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 185.1412 | 1.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 186.0509 | 0.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 187.0630 | 3.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 187.1555 | 1.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 188.0003 | 1.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 188.0631 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | BOC-ALA-OH (CAS# 15761-38-3); (M+NA)+ | 189.1007 | 9.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | 191.0254 | 0.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 191.0265 | 0.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 191.0582 | 2.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 192.1117 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 192.1472 | 0.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 193.1102 | 0.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 193.1412 | 17.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 194.0808 | 6.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 194.1062 | 4.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 194.1156 | 3.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 196.1073 | 12.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 196.1213 | 5.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 197.0801 | 1.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 197.1413 | 3.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 198.1000 | 2.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 199.0673 | 11.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 199.1935 | 18.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 200.0370 | 3.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 200.0812 | 1.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 200.1010 | 6.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 201.0990 | 3.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 201.1013 | 3.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 201.1382 | 2.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 202.0394 | 3.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 202.0451 | 0.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 203.0982 | 9.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 203.1160 | 0.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 203.1285 | 12.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 203.9730 | 1.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 204.0572 | 1.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 204.0759 | 1.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 204.0831 | 8.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 204.0900 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 204.1623 | 6.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 205.0744 | 7.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 205.1463 | 5.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | L-TRYPTOPHAN-15N2 [ISTD] (CAS# ); (M+H)+ | 206.0849 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | 208.0850 | 2.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 209.0443 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 209.1164 | 8.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 210.0886 | 10.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 210.1231 | 6.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 210.1233 | 13.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 210.1260 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 211.0365 | 0.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 211.1574 | 2.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 212.1390 | 14.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 213.9116 | 0.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 214.0091 | 1.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 214.0160 | 4.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 215.0573 | 5.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 216.0095 | 3.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 216.0905 | 4.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 216.0978 | 3.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 216.1485 | 20.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 217.0061 | 4.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 217.1317 | 1.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 218.0195 | 0.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 218.0912 | 1.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 218.1626 | 0.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 218.1779 | 2.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 219.1110 | 3.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 219.1124 | 3.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 220.0895 | 1.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 220.1787 | 0.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 221.0215 | 0.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 223.1555 | 4.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 224.1063 | 13.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 224.1363 | 13.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 224.1873 | 16.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 226.1169 | 12.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 226.1671 | 4.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 227.1877 | 16.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 228.1337 | 10.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 228.9691 | 1.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 229.0746 | 2.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 229.2408 | 17.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 230.0767 | 1.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 230.1633 | 3.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 231.1472 | 2.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 231.9788 | 5.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 232.0715 | 10.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 232.0870 | 18.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 232.1188 | 7.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 233.0930 | 1.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 234.0983 | 3.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 234.1730 | 5.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 236.0804 | 2.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 236.0810 | 2.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 236.1391 | 15.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 236.1396 | 18.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 236.1886 | 6.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 238.1279 | 21.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 238.1418 | 4.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 238.1548 | 18.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 239.0955 | 2.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 240.1334 | 15.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 240.1474 | 1.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 240.1705 | 15.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 2-(DIPHENYLMETHOXY)-N-METHYLETHYLAMINE (CAS# 17471-10-2); (M+H)+ | 241.1464 | 10.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | 242.0419 | 1.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 242.0817 | 11.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 243.1460 | 4.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 243.1831 | 15.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 243.2561 | 18.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 244.0735 | 15.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 244.1065 | 15.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 244.1779 | 6.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 245.1630 | 4.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 246.1215 | 2.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 246.1229 | 16.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 246.1376 | 4.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 246.1928 | 0.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 248.0474 | 1.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 248.0732 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 248.0735 | 13.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 248.0824 | 15.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 248.0828 | 14.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 248.1401 | 17.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 248.1481 | 0.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 248.1755 | 19.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 250.0718 | 3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 250.1228 | 18.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 251.1492 | 14.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 252.1383 | 18.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 252.2060 | 22.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 253.1430 | 0.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 254.0905 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 254.1604 | 16.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 254.1859 | 20.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 255.1032 | 8.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 256.0572 | 6.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 256.1094 | 18.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 256.1440 | 21.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 257.1033 | 0.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 257.1056 | 7.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 258.0876 | 13.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 258.1210 | 17.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 258.1237 | 15.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 259.1781 | 7.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 260.1032 | 14.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 260.1044 | 14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 260.1180 | 5.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 260.1241 | 4.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 260.1364 | 4.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 260.1373 | 4.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 260.1375 | 21.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 260.1738 | 0.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 261.1577 | 2.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 262.1146 | 17.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 262.1322 | 6.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 262.1459 | 0.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 263.1879 | 6.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 264.0771 | 15.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 264.1053 | 0.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 264.1117 | 5.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 265.1045 | 4.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 266.0936 | 13.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 266.1021 | 3.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 266.1549 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 266.1634 | 3.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 267.0767 | 21.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 267.1802 | 14.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 268.0825 | 1.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 268.1370 | 4.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 268.1525 | 1.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 268.2020 | 20.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 269.3086 | 18.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 270.0866 | 2.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 270.1136 | 3.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 270.1596 | 20.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 271.2495 | 18.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 272.1026 | 17.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 272.1033 | 18.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 272.1034 | 15.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 272.1426 | 20.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 272.1714 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 272.1746 | 19.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 272.1939 | 0.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 273.0306 | 3.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 273.2674 | 17.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 274.1026 | 4.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 274.1537 | 5.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 274.1642 | 0.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 275.1367 | 1.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 275.1372 | 1.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 276.0882 | 10.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 276.1055 | 18.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 276.2053 | 22.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 277.1168 | 1.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 278.0867 | 16.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 278.0922 | 17.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 278.1525 | 20.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 278.1631 | 8.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 278.1833 | 0.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 279.1319 | 1.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 279.2161 | 21.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 280.1014 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 280.1659 | 20.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 280.2014 | 21.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 280.2411 | 22.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 281.1139 | 1.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 281.1970 | 16.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 282.0976 | 2.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 282.1681 | 6.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 282.2174 | 21.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 283.0923 | 1.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 284.1244 | 18.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 284.1339 | 21.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 284.1389 | 8.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 285.1248 | 1.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 285.1942 | 9.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 286.1192 | 14.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 286.1889 | 0.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 287.1458 | 15.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 287.1951 | 1.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 287.2105 | 11.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 287.2460 | 20.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 287.2825 | 17.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 288.1347 | 16.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 288.1473 | 20.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 288.1701 | 20.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 289.1271 | 1.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 289.1531 | 2.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 289.2621 | 17.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 290.1099 | 9.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 290.1142 | 18.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 292.1746 | 22.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 292.2007 | 21.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 292.2019 | 19.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 293.1478 | 1.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 293.3229 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 294.0789 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 294.0876 | 5.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 294.1217 | 5.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 294.1648 | 20.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 295.0599 | 0.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 296.1968 | 21.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 296.2340 | 22.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 297.0902 | 4.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 297.1078 | 2.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 297.1690 | 0.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 297.1832 | 0.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 297.2654 | 19.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 297.3402 | 19.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 298.1044 | 12.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 298.1552 | 19.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 298.1888 | 22.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 298.2101 | 20.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 299.2826 | 20.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 299.3397 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 300.1346 | 20.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 300.1421 | 3.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 300.1704 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 300.2073 | 22.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 300.2776 | 17.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 301.1884 | 3.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 301.2068 | 18.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 301.2969 | 17.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 301.2972 | 21.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 303.2929 | 18.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 304.1431 | 17.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 304.1504 | 6.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 304.1995 | 0.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 304.2394 | 22.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 305.2464 | 17.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 306.0818 | 13.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 306.0883 | 19.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 306.1084 | 7.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 307.0848 | 1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 307.0851 | 0.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 308.1201 | 10.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 308.1977 | 21.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 308.2306 | 22.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 308.3170 | 21.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 309.1936 | 11.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 309.2286 | 20.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 310.1197 | 2.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 310.1792 | 17.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 310.2483 | 22.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 311.1044 | 1.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 311.1256 | 3.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 312.1373 | 20.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 312.1557 | 20.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 312.2210 | 22.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 312.2250 | 21.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 313.1560 | 4.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 313.2255 | 14.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 314.0732 | 0.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 314.1309 | 14.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 314.1355 | 0.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 314.1505 | 19.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 314.1852 | 21.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 314.2218 | 22.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 315.2041 | 5.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 315.2384 | 15.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 315.2757 | 15.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 315.3132 | 20.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 316.1299 | 17.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 316.2027 | 21.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 316.2385 | 23.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 317.1126 | 1.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 317.2930 | 17.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 318.1305 | 5.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 318.1881 | 22.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 319.0368 | 3.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 319.0877 | 1.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 320.1247 | 10.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 320.2668 | 23.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 321.0722 | 1.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 321.1806 | 1.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 322.2197 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 322.2456 | 22.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 322.2457 | 22.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 322.2532 | 22.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 323.2123 | 20.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 324.2052 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 324.2086 | 22.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 324.2290 | 22.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 324.2626 | 22.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 325.1161 | 1.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 325.3486 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 325.3715 | 21.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 326.1943 | 7.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 326.2236 | 22.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 326.2399 | 22.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 326.2881 | 22.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 327.1320 | 2.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 327.3116 | 21.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 327.8909 | 0.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 328.1309 | 8.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 328.2350 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 329.2563 | 16.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 329.3289 | 21.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 330.1817 | 19.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 330.1979 | 14.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 330.2185 | 22.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 331.1336 | 6.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 331.3244 | 20.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 332.1621 | 17.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 332.2707 | 22.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 333.2869 | 17.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 333.2944 | 23.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 334.0992 | 4.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 334.0996 | 7.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 334.1007 | 10.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 334.1191 | 20.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 334.2492 | 22.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 336.0982 | 18.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 336.1504 | 21.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 336.1623 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 336.2283 | 19.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 336.2285 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 336.2592 | 22.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 336.2648 | 22.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 337.2300 | 21.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 337.2579 | 21.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 338.2439 | 21.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 338.3137 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 339.2538 | 20.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 339.3259 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 340.1650 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 340.1979 | 21.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 340.2383 | 23.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 340.2567 | 22.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 341.1492 | 2.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 341.2554 | 16.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 342.1468 | 16.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 342.1489 | 1.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 342.1857 | 22.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 342.1891 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 342.2163 | 21.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 342.2351 | 20.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 342.2512 | 23.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 342.2881 | 19.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 343.0511 | 1.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 343.1267 | 1.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 343.2200 | 7.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 343.2701 | 17.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 343.2718 | 18.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 343.8690 | 0.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 345.1162 | 11.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 346.2103 | 0.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 346.2851 | 23.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 346.2857 | 23.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 347.0615 | 0.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 347.0627 | 0.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 348.0535 | 19.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 348.0752 | 4.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 348.1764 | 7.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 348.2102 | 22.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 349.0975 | 2.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 349.2925 | 23.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 350.1143 | 17.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 350.1299 | 19.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 350.1630 | 22.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 350.1907 | 12.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 350.2281 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 350.2465 | 22.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 351.1538 | 6.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 351.1548 | 4.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 351.1551 | 6.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 352.0952 | 10.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 352.1097 | 10.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 352.1289 | 22.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 352.1451 | 21.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 352.1453 | 20.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 352.2601 | 22.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 353.1605 | 1.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 354.0562 | 11.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 354.0679 | 1.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 354.2361 | 18.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 354.2528 | 23.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 354.2701 | 22.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 354.2742 | 22.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 355.2710 | 18.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 355.3450 | 21.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 356.0818 | 9.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 356.1968 | 15.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 356.2142 | 23.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 356.2332 | 22.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 356.2355 | 22.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 356.2384 | 0.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 356.2522 | 21.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 357.1070 | 0.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 357.1219 | 1.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 357.1937 | 20.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 357.2873 | 18.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 357.3004 | 22.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 357.3600 | 21.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 358.2231 | 17.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 359.3117 | 23.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 359.3164 | 23.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 359.3524 | 21.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 359.3560 | 21.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 360.2270 | 21.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 361.0926 | 1.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 361.3184 | 17.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 361.3280 | 23.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 362.1057 | 20.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 362.1551 | 6.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 362.2101 | 13.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 362.2496 | 22.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 362.2798 | 23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 362.2799 | 22.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 363.1129 | 1.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 364.1295 | 20.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 364.1298 | 20.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 364.2392 | 23.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 364.2947 | 23.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 364.3429 | 23.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 365.0919 | 2.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 365.1256 | 1.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 366.1273 | 12.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 366.1427 | 3.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 366.1434 | 2.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 366.1522 | 20.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 366.1614 | 21.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 366.1627 | 21.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 366.1794 | 22.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 366.2538 | 23.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 366.2541 | 23.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 366.3110 | 23.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 367.2537 | 22.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 367.2721 | 18.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 367.3235 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 367.4171 | 22.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 368.1073 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 368.1247 | 8.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 368.1778 | 21.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 368.2681 | 23.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 368.2849 | 22.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 368.3451 | 24.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 369.1500 | 2.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 369.2866 | 19.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 370.2206 | 8.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 370.2323 | 18.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 370.2632 | 22.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 371.1358 | 1.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 371.1698 | 3.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 371.3037 | 20.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 371.3390 | 21.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 372.0496 | 12.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 372.2268 | 20.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 372.2287 | 21.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 373.2911 | 22.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 374.2432 | 22.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 375.1640 | 9.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 375.2532 | 17.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 375.3092 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 376.1354 | 6.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 376.1397 | 7.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 376.2022 | 21.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 376.2612 | 22.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 376.2869 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 376.2877 | 22.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 376.2925 | 23.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 376.2992 | 23.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 377.1821 | 11.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 377.3267 | 23.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 378.0641 | 7.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 378.2771 | 22.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 379.1066 | 1.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 380.2527 | 20.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 380.2571 | 20.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 380.2917 | 22.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 381.1212 | 1.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 381.2687 | 22.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 382.1776 | 13.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 382.2711 | 22.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 383.1708 | 4.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 383.1875 | 22.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 384.0815 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 384.1242 | 1.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 384.1505 | 22.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 384.2815 | 22.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 384.3277 | 22.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 385.1485 | 2.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 385.3175 | 20.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 386.1737 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 386.1740 | 17.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 386.1772 | 22.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 386.2036 | 4.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 386.2462 | 21.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 386.2614 | 20.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 387.2465 | 8.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 387.3446 | 23.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 387.3864 | 21.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 388.1885 | 21.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 388.1901 | 22.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 388.2635 | 22.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 389.1392 | 15.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 390.0664 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 390.1009 | 21.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 390.2062 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 390.2816 | 23.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 390.3479 | 25.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 392.0036 | 11.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 392.1924 | 22.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 392.2027 | 8.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 392.2786 | 17.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 392.2915 | 23.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 392.3013 | 21.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 393.2683 | 22.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 393.2865 | 19.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 394.0556 | 22.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 394.3063 | 22.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 394.3416 | 23.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 395.3013 | 19.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 396.2249 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 396.2642 | 22.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 396.3201 | 23.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 396.3766 | 22.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 397.3179 | 20.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 397.3547 | 21.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 398.0208 | 11.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | S-ADENOSYLMETHIONINE (CAS# 29908-03-0); (M+H)+ | 398.1371 | 0.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | 398.1380 | 0.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 398.1385 | 0.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 398.2281 | 3.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 398.2443 | 21.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 398.2973 | 22.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 398.2976 | 22.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 399.1671 | 4.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 399.3357 | 21.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 399.3712 | 21.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 400.2603 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 400.3958 | 22.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 401.3498 | 21.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 401.3832 | 21.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 403.1951 | 14.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 403.2004 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 404.1177 | 22.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 404.1984 | 0.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 404.2001 | 1.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 404.2555 | 21.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 404.3295 | 23.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 404.4117 | 22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 405.1956 | 15.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 405.2103 | 15.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 405.3540 | 23.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 406.1818 | 7.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 406.2328 | 18.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 406.2337 | 17.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 406.3257 | 24.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 406.3384 | 23.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 406.3418 | 23.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 408.0857 | 1.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 408.1047 | 5.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 408.1531 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 408.1559 | 17.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 408.1560 | 18.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 408.1563 | 15.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 408.1568 | 17.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 408.1688 | 19.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 408.2228 | 18.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 408.2734 | 23.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 408.3187 | 22.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 408.3264 | 23.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 411.2022 | 8.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 411.3340 | 21.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 412.1828 | 22.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 412.2605 | 23.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 412.2654 | 20.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 412.3137 | 22.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 413.2044 | 17.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 413.2290 | 19.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 413.3506 | 21.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 414.2050 | 18.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 414.2054 | 19.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 414.2459 | 8.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 414.2713 | 21.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 414.2744 | 21.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 414.2963 | 22.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 415.9947 | 0.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 416.1964 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 417.2158 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 418.2710 | 22.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 418.3082 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 419.1875 | 1.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 420.1601 | 7.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 420.2263 | 21.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 420.2482 | 6.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 420.3101 | 17.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 420.3201 | 22.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 420.3949 | 24.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 421.3167 | 20.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 422.3179 | 23.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 422.3182 | 23.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 422.3227 | 23.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 422.3327 | 22.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 422.3724 | 24.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 423.1610 | 2.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 423.3358 | 21.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 424.1435 | 19.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 424.1470 | 16.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 424.1507 | 18.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 424.2086 | 21.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 424.2756 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 424.3326 | 23.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 424.3328 | 23.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 425.3508 | 21.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 426.0869 | 0.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 426.1233 | 19.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 426.2230 | 2.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 426.2530 | 22.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 426.2843 | 22.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 426.2845 | 22.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 426.3277 | 22.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 426.3433 | 23.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 427.1687 | 0.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 427.3657 | 21.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 428.2314 | 16.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 428.3103 | 22.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 429.2839 | 16.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 429.2956 | 22.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 429.3818 | 21.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 430.0951 | 8.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 430.2160 | 21.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 430.2894 | 21.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 431.2260 | 1.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 431.2295 | 17.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 431.2309 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 431.2313 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 431.2708 | 8.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 431.3026 | 20.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 432.2561 | 19.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 432.3561 | 23.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 433.1881 | 10.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 433.2408 | 18.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 433.3843 | 24.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 434.1607 | 22.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 434.2855 | 22.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 434.3399 | 23.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 435.3116 | 22.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 435.3354 | 23.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 436.1872 | 18.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 436.1872 | 18.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 436.1882 | 17.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 436.1900 | 20.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 436.2283 | 8.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 436.3033 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 436.3309 | 23.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 436.3435 | 23.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 438.3088 | 22.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 438.3111 | 21.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 440.2936 | 23.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 440.3272 | 23.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 441.1403 | 5.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 442.3274 | 22.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 444.1370 | 1.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 444.1759 | 1.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | MENAQUINONE (CAS# 11032-49-8); (M+H)+ | 444.3018 | 24.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | 444.3065 | 21.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 444.3236 | 19.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 445.1890 | 9.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 445.2337 | 16.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 445.2397 | 18.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 445.2466 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 446.0506 | 9.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 446.1296 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 446.4099 | 25.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 447.2011 | 1.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 447.3334 | 21.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 448.2135 | 2.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 448.2806 | 21.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 448.2855 | 22.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 448.2974 | 22.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 448.3187 | 23.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 448.3416 | 17.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 448.3547 | 23.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 448.3559 | 23.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 448.4265 | 25.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 449.3165 | 20.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 449.3484 | 21.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 450.2072 | 8.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 450.3483 | 23.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 452.1551 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 452.1653 | 1.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 452.2962 | 22.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 452.3318 | 24.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 452.3563 | 24.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 453.1758 | 2.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 453.2920 | 22.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 454.1549 | 20.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 454.3055 | 21.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 454.3149 | 23.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 454.3398 | 23.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 454.4532 | 22.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 456.1813 | 22.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 456.1826 | 1.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 456.2302 | 21.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 456.2570 | 7.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 456.3392 | 22.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 457.2411 | 18.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 457.3381 | 19.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 457.8449 | 0.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 458.1640 | 22.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 458.1957 | 23.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 458.1984 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 458.2429 | 22.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 458.2447 | 22.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 458.2721 | 9.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 458.3182 | 23.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 458.3214 | 22.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 458.3491 | 21.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 459.2057 | 17.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 459.2585 | 19.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 459.2590 | 19.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 459.2625 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 460.1774 | 22.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 460.3340 | 23.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 461.2727 | 20.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 462.0798 | 0.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 462.2965 | 22.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 462.3306 | 23.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 462.3343 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 462.3506 | 23.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 464.1274 | 1.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 464.2116 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 464.2153 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 464.2380 | 2.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 464.3103 | 22.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 464.3141 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 464.3191 | 22.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 464.3562 | 23.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 465.2099 | 8.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 465.2158 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 465.2223 | 17.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 465.2224 | 2.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 466.0958 | 23.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 466.2789 | 22.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 467.3025 | 21.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 467.3039 | 21.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 468.2880 | 22.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 468.3258 | 23.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 468.3520 | 23.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 468.3543 | 23.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 469.1375 | 1.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 469.2783 | 18.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 470.1194 | 22.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 470.1253 | 18.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 470.1264 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 470.3227 | 22.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 470.3495 | 22.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 470.4792 | 23.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 471.2965 | 20.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 471.3338 | 21.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 472.1931 | 12.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 472.2497 | 21.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 472.3157 | 27.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 472.3331 | 22.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 472.3442 | 23.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 473.2434 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 473.2658 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 474.3249 | 21.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 474.3278 | 22.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 474.3567 | 17.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 475.2718 | 22.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 475.2965 | 9.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 475.3025 | 22.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 476.1432 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 476.1690 | 3.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 476.3539 | 23.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 477.2888 | 22.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 477.3127 | 20.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 479.1558 | 3.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 479.3071 | 22.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 480.2540 | 9.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 480.3461 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 480.3916 | 12.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 480.3942 | 24.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 481.3174 | 22.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 481.3521 | 22.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 482.1157 | 3.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 482.1843 | 3.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 482.3417 | 23.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 483.1108 | 0.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 483.1109 | 1.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 483.2573 | 19.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 484.1044 | 22.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 484.1411 | 19.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 484.1814 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 484.2626 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 484.3507 | 23.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 484.3558 | 23.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 485.2771 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 485.2776 | 17.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 486.1791 | 4.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 486.2802 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 486.3527 | 22.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 486.3635 | 23.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 486.3637 | 23.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 486.3652 | 23.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 486.3659 | 23.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 487.2618 | 20.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 487.2906 | 20.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 487.2912 | 18.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 487.2935 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 488.2136 | 21.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 488.3240 | 21.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 489.3026 | 21.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 489.3030 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 492.1422 | 3.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 492.3055 | 21.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 492.3372 | 22.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 493.2459 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 493.3186 | 21.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 494.2336 | 9.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 495.3314 | 22.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 496.1340 | 22.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 496.3507 | 23.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 496.5021 | 22.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 496.5072 | 23.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 498.1100 | 2.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 498.1227 | 22.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 498.1579 | 18.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 498.3381 | 22.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 498.3464 | 23.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 500.3110 | 19.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 500.3115 | 19.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 500.3405 | 21.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 500.3637 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 501.1718 | 8.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 501.2779 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 501.2820 | 22.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 501.2902 | 22.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 501.2931 | 22.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 501.3226 | 22.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 502.1446 | 1.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 502.1759 | 2.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 502.2984 | 10.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 502.3257 | 18.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 502.3270 | 19.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 502.3271 | 18.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 502.3280 | 19.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 502.3643 | 22.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 503.2995 | 22.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 503.3026 | 22.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 503.3041 | 21.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 504.1749 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 504.1756 | 19.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 504.1762 | 18.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 504.2749 | 20.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 504.3816 | 23.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 505.2529 | 21.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 506.3209 | 22.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 506.3465 | 23.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 506.3964 | 23.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 508.3371 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 508.3374 | 22.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 509.2954 | 6.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 510.2047 | 22.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 511.3276 | 19.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 511.3850 | 19.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 512.1420 | 23.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 512.3421 | 22.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 512.4072 | 23.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 513.3055 | 21.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 513.3074 | 19.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 513.3087 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 514.2580 | 20.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 514.3437 | 22.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 514.3754 | 22.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 514.5255 | 22.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 515.3010 | 21.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 515.3196 | 21.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 516.2887 | 19.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 517.3300 | 22.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 518.1202 | 0.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 518.1202 | 0.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 518.3021 | 19.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 518.3219 | 17.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 518.3229 | 17.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 518.3230 | 18.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 518.3865 | 23.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 519.3332 | 22.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 519.5032 | 24.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 520.1344 | 22.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 520.4269 | 27.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 521.2538 | 21.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 521.3439 | 22.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 521.3458 | 22.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 521.5907 | 22.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 522.1542 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 522.2804 | 18.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 523.3631 | 22.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 523.3658 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 524.1642 | 22.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 524.2224 | 22.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 524.2807 | 10.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 524.3741 | 23.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 525.2913 | 22.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 525.4022 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 526.0745 | 1.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 526.1507 | 0.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 526.1829 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 526.2007 | 21.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 526.3683 | 23.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 527.2398 | 3.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 527.3055 | 22.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 527.3085 | 22.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 527.3342 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 528.3238 | 23.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 528.3966 | 23.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 529.3172 | 22.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 529.3548 | 22.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 530.2146 | 20.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 530.3977 | 23.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 530.4018 | 23.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 531.3316 | 22.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 531.3344 | 22.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 531.3617 | 22.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 531.4642 | 23.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 532.3541 | 21.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 532.4172 | 24.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 533.1830 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 533.2845 | 22.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 533.2847 | 22.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 533.3051 | 19.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 533.3107 | 21.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 533.3111 | 19.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 533.4763 | 24.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 534.2948 | 18.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 534.2966 | 18.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 534.3151 | 17.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 534.3164 | 16.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 534.3835 | 22.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 535.1812 | 2.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 536.1624 | 1.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 536.3288 | 21.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 536.3568 | 23.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 536.3880 | 25.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 537.1206 | 1.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 537.3029 | 21.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 537.5151 | 24.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 538.1032 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 538.2337 | 22.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 538.2603 | 10.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 538.3658 | 22.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 539.3023 | 21.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 539.3025 | 21.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 540.1140 | 24.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 540.2156 | 21.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 541.0601 | 1.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 541.3175 | 22.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 541.3182 | 22.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 542.1243 | 0.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 542.2066 | 3.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 543.1100 | 24.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 543.3293 | 22.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 543.4628 | 22.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 545.2520 | 22.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 545.2540 | 22.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 545.2826 | 18.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 545.3469 | 22.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 545.4793 | 24.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 546.3246 | 10.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 546.3745 | 22.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 547.2753 | 22.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 547.2758 | 22.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 547.4339 | 23.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 547.4537 | 23.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 548.4572 | 29.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 548.6918 | 22.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 549.1204 | 1.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 549.1552 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 549.4048 | 23.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 549.6200 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 550.1867 | 21.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 550.3478 | 22.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 550.6091 | 22.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 550.8048 | 22.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 550.8226 | 22.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 551.2594 | 21.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 551.3039 | 22.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 552.2569 | 22.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 552.3504 | 22.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 552.3842 | 23.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 553.2658 | 18.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 554.2322 | 21.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 554.5046 | 28.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 555.2893 | 20.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 556.4354 | 23.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 557.2721 | 21.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 557.2853 | 21.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 557.2860 | 22.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 557.2866 | 22.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 557.3092 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 557.3475 | 22.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 557.4799 | 24.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 558.1228 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 558.3739 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 558.4308 | 24.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 559.3033 | 22.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 559.3251 | 20.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 559.4949 | 22.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 559.4979 | 24.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 560.2883 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 560.3781 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 561.1208 | 22.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 561.2828 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 561.3067 | 21.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 561.3179 | 22.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 561.3420 | 21.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 561.4555 | 24.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 561.4696 | 23.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 561.5105 | 24.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 562.3655 | 21.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 562.4579 | 25.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 562.6090 | 22.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 563.3006 | 21.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 563.3015 | 21.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 563.4222 | 23.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 564.2972 | 19.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 564.2979 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 565.3168 | 22.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 567.3263 | 22.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 567.3324 | 22.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 567.4177 | 23.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 568.3071 | 10.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 568.3741 | 23.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 569.2567 | 22.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 569.3365 | 22.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 569.4324 | 24.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 570.1393 | 22.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 570.3130 | 19.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 570.3143 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 570.3914 | 23.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 570.4114 | 23.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 571.2730 | 22.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 571.2886 | 22.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 571.2888 | 21.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 571.4981 | 24.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 571.8252 | 0.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 572.2912 | 3.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 572.3337 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 573.2493 | 21.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 573.2732 | 21.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 573.3805 | 23.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 573.4576 | 24.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 573.4729 | 23.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 573.5107 | 24.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 574.4003 | 22.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 574.4903 | 27.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 575.2752 | 22.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 575.2780 | 22.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 575.3211 | 22.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 575.3345 | 22.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 575.4836 | 23.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 575.4906 | 24.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 576.3790 | 21.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 576.4724 | 25.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 576.5066 | 27.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 576.6888 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 576.6945 | 25.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 577.2795 | 21.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 577.4969 | 24.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 578.2866 | 20.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 579.1401 | 1.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 579.2894 | 22.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 579.2918 | 22.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 579.4473 | 23.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 580.2922 | 18.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 580.3545 | 21.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 581.2808 | 22.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 581.2944 | 21.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 581.3076 | 20.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 581.3093 | 2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 581.3150 | 20.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 582.1989 | 3.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 582.2156 | 3.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 583.1529 | 0.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 583.2883 | 21.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 583.3101 | 21.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 584.2646 | 15.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 584.4063 | 23.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 585.3024 | 22.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 585.3037 | 22.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 585.5104 | 24.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 586.1556 | 23.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 586.3096 | 18.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 586.4601 | 24.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 587.4385 | 23.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 587.8095 | 0.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 588.4188 | 22.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 588.4746 | 25.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | GUANOSINE 5'-DIPHOSPHO-BETA-L-FUCOSE (CAS# 0); (M+H)+ | 589.0836 | 0.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | 589.3155 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 589.3157 | 22.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 589.3210 | 22.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 589.5394 | 25.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 590.1377 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 590.2891 | 10.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 590.4895 | 26.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 590.6535 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 591.3174 | 21.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 591.3311 | 22.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 592.3837 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 593.3446 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 593.3595 | 22.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 593.4613 | 23.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 594.1680 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 594.3729 | 22.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 594.6202 | 22.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 595.1305 | 1.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 596.3186 | 19.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 596.3209 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 596.3268 | 6.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 597.3055 | 22.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 597.3069 | 22.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 597.3431 | 22.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 598.0852 | 1.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 598.1097 | 21.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 598.1612 | 22.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 598.4225 | 23.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 598.4242 | 22.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 598.4341 | 22.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 599.2767 | 22.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 599.2796 | 22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 599.3224 | 22.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 599.3295 | 22.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 600.1836 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 600.2865 | 20.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 600.4045 | 23.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 600.4396 | 23.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 600.5104 | 27.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 601.2940 | 19.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 601.2971 | 19.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 601.5379 | 25.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 602.4338 | 22.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 602.4902 | 26.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 602.4912 | 25.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 602.5243 | 27.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 602.6531 | 22.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 603.2911 | 22.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 603.2917 | 22.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 603.3665 | 22.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 604.2330 | 18.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 604.4080 | 22.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 604.4509 | 25.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 604.4934 | 17.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 604.5051 | 26.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 604.5065 | 28.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 605.3050 | 22.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 606.0933 | 22.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 606.3934 | 21.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 606.4672 | 26.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 607.2889 | 21.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 607.2944 | 21.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 607.3265 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 607.4723 | 24.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 608.3820 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 609.3033 | 22.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 609.3036 | 22.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 609.3047 | 22.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 609.4579 | 23.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 609.5702 | 22.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 610.6036 | 24.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 611.1229 | 2.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 611.3125 | 22.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 611.3180 | 22.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 612.1525 | 1.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | GLUTATHIONE (CAS# 27025-41-8); (M+H)+ | 612.1526 | 1.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | GLUTATHIONE (CAS# 27025-41-8); (M+H2)+2 | 612.1549 | 1.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | 612.2758 | 20.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 612.3332 | 11.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 612.4090 | 23.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 613.2394 | 22.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 613.2405 | 22.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 613.2946 | 0.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 613.3350 | 22.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 613.3358 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 614.1331 | 24.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 614.4182 | 23.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 614.4898 | 25.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 614.6651 | 22.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 614.6677 | 23.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 614.6704 | 22.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 614.7348 | 25.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 615.3493 | 22.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 616.1622 | 1.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 616.2522 | 3.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 616.4639 | 22.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 616.5057 | 26.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 616.5058 | 26.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 617.5687 | 26.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 618.4228 | 22.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 618.4788 | 23.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 618.5202 | 27.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 620.2296 | 21.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 620.4024 | 21.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 620.4444 | 23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 621.4665 | 24.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 622.4314 | 22.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 622.5010 | 26.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 623.2761 | 22.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 624.2964 | 10.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 624.3820 | 21.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 624.4440 | 22.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 624.5117 | 26.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 624.6674 | 22.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 625.2600 | 21.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 625.2659 | 21.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 625.3356 | 22.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 626.4306 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 627.2915 | 22.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 627.4271 | 23.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 627.4859 | 24.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 628.2602 | 3.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 628.4275 | 23.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 629.2473 | 3.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 629.3303 | 21.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 629.4442 | 23.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 629.5726 | 26.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 630.0008 | 13.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 630.1361 | 20.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 630.4202 | 23.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 630.4613 | 25.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 630.4732 | 23.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 630.5224 | 27.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 630.5227 | 27.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 630.6814 | 22.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 630.6829 | 22.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 631.2903 | 21.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 631.2906 | 21.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 631.3082 | 14.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 632.1134 | 22.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 632.1318 | 18.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 632.1443 | 22.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 632.2887 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 632.3868 | 22.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 632.4456 | 22.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 632.4790 | 26.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 632.6399 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 633.3039 | 22.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 634.4720 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 634.4941 | 27.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 635.3245 | 22.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 635.3247 | 22.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 636.2997 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 636.4202 | 22.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 636.5167 | 26.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 636.6688 | 22.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 637.3297 | 22.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 637.3761 | 22.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 637.5952 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 638.1220 | 22.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 638.3047 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 638.3920 | 22.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 638.4014 | 22.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 638.4904 | 25.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 638.4909 | 25.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 638.6574 | 22.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 638.7521 | 25.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 639.1701 | 7.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 639.2772 | 22.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 639.5472 | 25.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 639.5809 | 22.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 640.5058 | 26.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 641.3273 | 8.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 641.3622 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 641.3689 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 641.4590 | 23.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 641.5728 | 26.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 642.3210 | 5.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 642.3847 | 22.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 642.5215 | 26.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 642.6442 | 22.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 642.6467 | 22.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 643.2261 | 21.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 643.3786 | 22.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 643.5842 | 26.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 643.5889 | 27.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 644.1220 | 0.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 644.5389 | 28.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 644.6744 | 22.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 645.5957 | 27.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 646.1561 | 23.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 646.4071 | 22.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 646.4085 | 23.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 646.4153 | 23.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 646.4187 | 22.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 646.4320 | 22.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 646.5523 | 29.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 647.2768 | 22.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 648.4227 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 648.5109 | 26.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 649.1505 | 23.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 649.2999 | 20.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 650.1017 | 1.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 650.1078 | 0.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 650.2135 | 3.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 650.4173 | 21.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 650.4237 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 650.4920 | 25.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 650.5221 | 27.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 650.5243 | 27.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 650.5271 | 27.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 650.5272 | 27.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 651.2163 | 0.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 651.2798 | 21.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 651.2802 | 21.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 652.5043 | 26.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 652.5413 | 28.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 653.2906 | 22.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 653.2930 | 22.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 653.5915 | 22.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 653.6065 | 28.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 654.4759 | 23.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 654.7346 | 25.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 655.4627 | 23.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 655.5862 | 26.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 655.5865 | 26.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 656.4807 | 26.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 656.4986 | 23.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 657.2986 | 22.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 657.3075 | 22.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 657.4747 | 24.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 657.5443 | 26.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 657.5964 | 27.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 657.6061 | 28.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 658.1165 | 22.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 658.2813 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 658.4982 | 26.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 658.4999 | 26.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 659.3203 | 22.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 659.3223 | 22.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 659.3719 | 22.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 659.5639 | 27.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 659.6163 | 28.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 659.6326 | 22.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 660.1344 | 22.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 660.1740 | 23.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 660.5175 | 28.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 660.5349 | 29.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 661.3892 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 661.5937 | 26.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 662.1554 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 662.2317 | 21.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 662.4363 | 23.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 662.4385 | 23.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 662.4553 | 22.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 662.4861 | 25.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 662.4875 | 25.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 662.4885 | 25.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 662.4923 | 25.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 663.1061 | 1.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | NAD (CAS# 53-84-9); (M+NA)+ | 663.1081 | 1.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | 663.1091 | 1.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | NAD (CAS# 53-84-9); (M+H)+ | 663.1093 | 1.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | NAD (CAS# 53-84-9); (M+2H)+2 | 663.1110 | 1.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001156 | 664.1464 | 22.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 664.4116 | 22.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 664.7827 | 25.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 665.4808 | 24.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 666.0721 | 1.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 666.1601 | 22.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 666.1844 | 3.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 666.4399 | 21.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 666.5215 | 26.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 666.5219 | 26.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 667.2688 | 22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 667.3493 | 22.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 667.3620 | 6.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 667.5883 | 26.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 667.6093 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 668.0846 | 0.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 668.1722 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 668.4052 | 22.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 668.4949 | 23.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 668.5397 | 27.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 669.2853 | 19.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 669.3381 | 22.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 669.6049 | 27.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 671.2488 | 22.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 671.4119 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 671.6161 | 28.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 671.6205 | 29.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 672.5079 | 26.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 672.6760 | 22.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 672.6857 | 22.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 673.3940 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 673.6349 | 29.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 674.2563 | 22.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 674.2776 | 21.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 674.4183 | 23.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 674.4208 | 23.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 674.5293 | 27.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 675.2810 | 21.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 675.4131 | 22.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 676.4545 | 23.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 676.4685 | 22.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 676.5439 | 28.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 677.2918 | 21.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 677.2932 | 22.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 677.3127 | 14.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 677.5915 | 25.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 677.8784 | 25.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 678.3411 | 11.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 678.4336 | 22.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 678.5214 | 26.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 678.5515 | 29.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 679.3070 | 22.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 680.5340 | 27.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 681.2269 | 22.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 681.2275 | 22.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 681.3248 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 681.3267 | 22.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 681.3597 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 681.4074 | 22.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 681.5969 | 27.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 681.6261 | 22.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 682.4265 | 22.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 682.4961 | 26.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 682.5018 | 23.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 683.3426 | 22.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 683.5559 | 26.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 683.5800 | 24.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 683.6186 | 28.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 684.4286 | 25.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 685.5044 | 24.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 685.5754 | 27.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 686.5688 | 27.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 687.2315 | 21.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 687.4073 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 687.5942 | 29.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 687.6054 | 26.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 688.5100 | 25.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 688.5171 | 24.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 688.5517 | 23.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 688.8075 | 25.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 689.5162 | 24.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 689.6260 | 27.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 690.3129 | 22.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 690.4332 | 19.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 690.4389 | 22.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 690.4789 | 23.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 690.5217 | 26.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 690.5229 | 26.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 690.7339 | 22.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 691.6012 | 26.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 692.4529 | 22.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 692.5364 | 27.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 692.7110 | 22.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 693.2490 | 21.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 693.2593 | 22.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 694.2570 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 694.4146 | 22.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 694.4622 | 24.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 694.4693 | 22.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 694.5015 | 23.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 694.5554 | 28.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 695.2562 | 22.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 695.3713 | 22.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 695.6162 | 27.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 695.6435 | 22.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 696.4367 | 22.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 696.4662 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 696.5208 | 23.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 697.2651 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 697.4171 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 698.4265 | 23.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 698.4305 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 698.5262 | 23.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 698.6988 | 22.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 699.2786 | 22.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 699.2796 | 22.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 699.2817 | 21.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 699.3301 | 2.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 699.4899 | 23.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 700.2755 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 700.5576 | 23.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 701.2978 | 22.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 701.3530 | 5.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 702.4521 | 24.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 702.4790 | 23.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 702.5696 | 24.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 703.3132 | 22.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 703.4365 | 22.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 703.5261 | 24.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 704.4127 | 22.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 704.5005 | 23.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 704.5807 | 24.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 705.5352 | 24.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 705.6224 | 27.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 706.4744 | 22.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 706.6413 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 707.2565 | 22.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 707.4163 | 22.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 708.4908 | 26.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 708.5134 | 27.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 708.5257 | 23.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 708.5685 | 28.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 709.3897 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 710.3975 | 21.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 710.5363 | 28.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 710.5365 | 23.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 711.3285 | 6.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 711.3820 | 22.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 711.4529 | 23.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 711.5223 | 24.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 712.4318 | 22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 712.6600 | 22.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 713.4714 | 23.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 713.4999 | 24.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 713.5350 | 24.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 714.6794 | 22.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 715.2660 | 22.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 715.2661 | 22.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 715.3673 | 22.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 716.2401 | 22.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 716.5796 | 24.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 717.0267 | 1.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 717.5335 | 24.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 717.5861 | 25.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 718.4198 | 22.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 719.2626 | 21.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 719.5299 | 23.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 719.5480 | 24.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 719.6395 | 27.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 720.1788 | 23.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 720.2532 | 22.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 720.4781 | 24.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 720.4951 | 22.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 721.2794 | 22.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 721.2834 | 22.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 721.4712 | 23.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 722.3743 | 12.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 722.5399 | 23.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 722.6890 | 12.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 723.3303 | 10.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 723.4019 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 723.5283 | 24.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 723.5497 | 24.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 724.5060 | 23.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 725.3954 | 22.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 725.4327 | 22.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 725.4794 | 23.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 725.5001 | 23.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 726.0326 | 24.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 726.2697 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 726.4526 | 22.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 726.5631 | 24.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 727.5168 | 24.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 729.4489 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 729.5349 | 24.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 729.7368 | 22.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 730.1409 | 23.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 730.5961 | 24.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 731.4646 | 22.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 731.5515 | 24.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 732.5375 | 23.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 733.4706 | 24.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 733.5068 | 23.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 733.5649 | 24.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 733.6552 | 28.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 735.5359 | 25.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 736.3987 | 22.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 736.4793 | 22.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 736.4863 | 23.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 736.5496 | 24.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 737.5396 | 24.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 737.5423 | 23.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 738.5392 | 23.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 738.5664 | 24.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 739.2628 | 22.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 739.2638 | 22.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 739.4069 | 22.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 739.4915 | 23.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 739.5503 | 25.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 739.5531 | 24.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 740.4503 | 22.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 740.5248 | 24.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 740.5506 | 23.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 741.2684 | 22.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 741.5026 | 23.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 741.5331 | 24.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 742.0778 | 10.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 742.4240 | 22.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 743.4048 | 22.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 743.4752 | 22.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 743.4819 | 24.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 743.5131 | 24.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 744.4821 | 24.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 745.2035 | 0.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 745.2802 | 22.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 745.2819 | 22.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 745.5640 | 24.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 745.5891 | 25.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 745.6188 | 26.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 747.2933 | 22.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 747.4875 | 23.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 748.4452 | 22.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 748.5256 | 23.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 748.5479 | 24.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 749.3087 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 749.3121 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 749.4533 | 23.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 749.4993 | 23.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 749.4996 | 23.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 749.5409 | 24.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 750.4154 | 22.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 750.4978 | 23.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 750.5109 | 22.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 750.5140 | 22.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 750.5693 | 24.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 751.5179 | 24.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 753.0217 | 24.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 756.3846 | 22.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 757.5644 | 24.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 759.5135 | 24.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 759.5188 | 23.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 761.5040 | 24.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 761.5089 | 24.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 761.5111 | 24.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 761.9339 | 25.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 762.1720 | 26.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 762.4079 | 22.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 762.4081 | 22.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 762.4969 | 23.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 764.4488 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 764.5005 | 23.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 764.5046 | 23.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 764.5271 | 22.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 765.4161 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 765.5316 | 24.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 765.5656 | 25.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 766.3963 | 12.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 767.4334 | 22.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 767.4422 | 22.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 767.4716 | 23.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 767.4994 | 22.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 767.5470 | 24.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 769.2780 | 22.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 769.2781 | 22.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 769.4561 | 22.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 769.5002 | 24.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 769.5293 | 23.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 769.5960 | 26.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 770.4788 | 22.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 771.4124 | 4.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 771.5164 | 23.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 773.5029 | 23.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 774.2092 | 1.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 774.6293 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 775.3721 | 22.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 775.5143 | 23.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 775.5159 | 24.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 776.5131 | 23.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 776.5187 | 24.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 776.5587 | 23.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 777.5306 | 24.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 778.5261 | 23.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 779.5325 | 22.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 779.5461 | 24.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 780.1789 | 23.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 780.5047 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 780.6423 | 22.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 781.4900 | 24.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 782.5140 | 24.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 782.5682 | 23.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 783.2504 | 22.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 783.2553 | 22.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 783.9316 | 25.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 784.4677 | 22.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 785.5249 | 24.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 785.5932 | 25.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 787.4969 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 787.4992 | 22.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 787.5146 | 23.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 787.5238 | 24.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 787.5288 | 24.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 787.5467 | 24.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 787.5488 | 24.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 787.6118 | 26.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 787.6128 | 25.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 787.9630 | 25.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 788.2423 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 789.2663 | 22.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 789.2688 | 22.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 789.4617 | 23.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 789.5302 | 25.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 789.5307 | 25.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 790.5230 | 23.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 791.5776 | 25.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 791.9394 | 25.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 792.4669 | 22.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 792.5395 | 24.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 792.5478 | 23.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 792.5489 | 22.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 793.4868 | 23.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 793.5142 | 22.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 793.5207 | 22.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 793.5226 | 24.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 793.5606 | 24.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 793.5618 | 24.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 793.5969 | 25.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 793.9558 | 25.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 793.9562 | 25.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 794.1965 | 23.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 794.2007 | 23.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 794.2582 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 794.2633 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 794.3284 | 16.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 794.4392 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 794.4479 | 22.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 794.6319 | 26.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 794.6552 | 22.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 795.5052 | 24.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 795.5122 | 24.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 795.5249 | 24.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 795.5380 | 23.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 795.5452 | 23.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 795.5772 | 25.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 795.6093 | 26.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 795.6113 | 26.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 797.5517 | 24.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 797.5540 | 23.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 797.5542 | 23.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 797.5928 | 26.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 798.1268 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 799.5138 | 23.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 799.9199 | 25.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 799.9216 | 25.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 801.5303 | 24.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 801.5322 | 24.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 802.5384 | 23.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 803.5460 | 24.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 803.5469 | 24.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 803.5476 | 24.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 805.0516 | 24.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 805.4988 | 23.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 805.5626 | 24.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 807.2439 | 22.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 807.2453 | 22.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 807.4229 | 19.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 807.5031 | 24.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 807.5789 | 24.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 808.6406 | 26.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 808.6454 | 26.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 809.5216 | 24.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 809.9499 | 25.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 810.4214 | 12.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 810.6485 | 27.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 811.5296 | 23.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 811.5360 | 23.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 811.5403 | 23.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 811.5411 | 23.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 811.5441 | 24.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 811.5457 | 23.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 811.5568 | 24.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 813.2625 | 22.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 813.2642 | 22.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 813.5326 | 24.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 814.5045 | 22.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 815.2816 | 22.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 815.4750 | 23.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 815.5454 | 24.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 815.5804 | 25.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 816.5304 | 22.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 816.5484 | 24.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 817.3001 | 22.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 817.4850 | 23.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 817.4908 | 23.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 817.5117 | 22.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 817.5146 | 22.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 817.5260 | 23.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 817.5610 | 24.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 817.5948 | 25.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 817.5990 | 25.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 817.9742 | 25.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 818.5544 | 24.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 819.5022 | 24.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 819.5035 | 24.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 819.5046 | 24.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 819.5050 | 24.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 819.5203 | 24.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 819.5437 | 23.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 819.5441 | 23.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 819.5465 | 23.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 820.5698 | 24.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 820.5716 | 23.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 820.6423 | 26.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 820.6436 | 26.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 820.6456 | 26.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 820.6463 | 26.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 820.6747 | 22.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 821.4868 | 23.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 821.4972 | 23.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 821.5217 | 24.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 822.6565 | 23.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 822.6593 | 27.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 823.5347 | 24.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 823.5360 | 25.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 823.5406 | 25.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 823.5708 | 23.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 823.5724 | 24.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 823.5741 | 23.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 823.6090 | 26.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 823.8979 | 22.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 823.9059 | 23.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 824.5328 | 22.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 825.5313 | 24.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 825.9482 | 25.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 827.5459 | 24.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 827.5480 | 24.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 827.5538 | 24.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 829.5616 | 24.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 829.5626 | 24.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 829.5631 | 24.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 829.5632 | 24.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 830.3992 | 22.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 830.5397 | 22.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 831.5746 | 24.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 831.5767 | 25.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 831.5796 | 25.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 832.5009 | 23.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 832.6436 | 26.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 832.6452 | 26.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 832.8967 | 22.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 833.5178 | 24.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 833.5884 | 25.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 834.6594 | 26.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 834.6626 | 27.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 835.5043 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 835.5336 | 24.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 835.5347 | 24.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 835.6053 | 26.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 835.6058 | 25.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 835.9314 | 25.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 835.9350 | 26.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 835.9414 | 26.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 836.4930 | 22.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 836.5793 | 23.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 836.6760 | 28.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 837.5059 | 24.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 837.5414 | 25.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 837.5481 | 25.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 837.5883 | 26.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 837.6335 | 27.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 839.5728 | 24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 841.4979 | 23.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 841.5434 | 23.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 841.5451 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 841.5489 | 22.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 841.9815 | 25.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 842.6180 | 22.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 843.5024 | 24.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 843.5135 | 24.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 843.5321 | 22.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 843.5359 | 23.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 843.5465 | 23.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 845.5214 | 24.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 845.5314 | 24.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 845.5335 | 24.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 845.5512 | 23.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 845.6324 | 27.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 845.9829 | 25.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 845.9911 | 25.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 846.6490 | 26.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 847.5350 | 24.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 847.5441 | 25.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 848.6315 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 849.5503 | 25.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 850.3906 | 19.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 851.5470 | 24.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 851.6105 | 24.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 851.9642 | 25.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 852.9677 | 25.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 853.5642 | 24.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 853.5645 | 24.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 854.0366 | 22.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 854.1974 | 23.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 854.4451 | 13.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 854.4874 | 23.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 855.5080 | 23.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 855.5637 | 23.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 855.5769 | 24.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 855.5801 | 25.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 857.5164 | 24.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 857.5947 | 25.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 857.5949 | 25.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 857.5951 | 25.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 858.5097 | 23.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 858.5309 | 22.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 858.5594 | 23.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 859.6041 | 25.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 859.6088 | 26.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 860.5274 | 24.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 860.6795 | 27.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 861.4824 | 23.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 861.5046 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 861.5059 | 22.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 861.5060 | 24.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 861.5123 | 24.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 861.5464 | 24.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 861.5488 | 24.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 861.5488 | 24.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 862.2477 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 862.6785 | 23.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 863.4969 | 24.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 863.5323 | 24.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 863.5590 | 25.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 863.5634 | 25.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 863.5649 | 25.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 864.6069 | 23.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 865.5211 | 24.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 865.5385 | 24.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 865.5511 | 23.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 865.5592 | 23.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 867.5068 | 23.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 867.5302 | 22.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 867.5307 | 22.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 867.5312 | 22.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 868.4905 | 23.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 868.5634 | 22.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 868.7016 | 23.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 869.5172 | 24.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 869.5190 | 24.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 871.5328 | 24.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 871.5338 | 24.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 871.5355 | 24.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 871.5613 | 22.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 871.6415 | 27.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 873.5490 | 24.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 875.3846 | 22.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 875.5389 | 24.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 875.5644 | 25.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 875.5649 | 25.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 875.5671 | 25.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 876.6329 | 26.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 877.5170 | 24.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 877.5633 | 24.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 877.5812 | 25.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 877.5853 | 26.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 877.9877 | 25.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 877.9944 | 25.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 878.7143 | 23.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 879.5804 | 24.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 879.5812 | 24.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 880.5162 | 22.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 880.6000 | 23.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 881.4623 | 24.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 881.5151 | 24.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 881.5218 | 24.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 881.5530 | 24.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 881.5694 | 23.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 882.5143 | 24.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 883.5189 | 24.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 883.5241 | 24.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 883.6029 | 23.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 884.0098 | 25.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 884.0169 | 25.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 885.5499 | 24.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 885.5508 | 24.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 885.5784 | 25.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 885.5838 | 25.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 886.0071 | 25.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 886.0079 | 25.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 886.6023 | 23.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 887.4944 | 24.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 888.5463 | 24.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 888.6271 | 26.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 888.6317 | 26.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 888.6326 | 26.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 888.6365 | 26.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 889.5105 | 24.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 889.5783 | 25.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 889.5794 | 25.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 890.5470 | 22.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 890.5493 | 22.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 890.6471 | 27.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 891.5185 | 24.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 891.5206 | 25.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 891.5227 | 24.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 891.5595 | 23.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 891.5620 | 23.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 891.5997 | 26.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 891.6037 | 26.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 893.5200 | 24.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 893.5463 | 24.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 893.5568 | 25.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 894.9883 | 25.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 895.4498 | 5.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 895.4525 | 5.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 895.5335 | 24.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 895.5390 | 24.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 895.5408 | 22.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 895.5461 | 23.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 897.5502 | 24.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 897.6143 | 23.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 898.3788 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 898.4697 | 22.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 898.4734 | 13.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 899.5631 | 24.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 899.5650 | 25.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 900.4218 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 900.6247 | 26.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 900.6337 | 26.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 901.5786 | 25.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 902.5574 | 22.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 902.5988 | 23.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 902.6455 | 27.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 902.6458 | 26.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 902.7303 | 23.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 902.7317 | 23.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 903.5209 | 24.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 903.5949 | 26.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 904.6625 | 28.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 905.4533 | 24.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 905.5865 | 24.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 905.6223 | 27.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 907.4723 | 24.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 907.6840 | 25.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 908.6437 | 23.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 910.0278 | 25.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 910.0335 | 25.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 910.5944 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 911.4950 | 24.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 911.5174 | 22.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 911.5272 | 22.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 911.5281 | 23.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 911.6312 | 24.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 913.2333 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 913.5468 | 23.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 913.6192 | 26.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 913.6219 | 27.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 914.0162 | 25.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 914.7038 | 23.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 915.5225 | 24.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 916.0004 | 22.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 918.5932 | 22.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 919.5308 | 24.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 919.9977 | 25.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 921.5508 | 24.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 921.5509 | 24.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 922.4992 | 24.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 923.4805 | 22.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 923.5630 | 24.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 923.5666 | 25.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 924.2131 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 924.5486 | 22.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 924.6319 | 23.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 925.4693 | 24.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 925.5798 | 25.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 926.5013 | 23.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 928.2206 | 23.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 928.5149 | 24.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 929.0661 | 22.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 929.0748 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 929.4888 | 24.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 929.4956 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 929.6092 | 26.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 930.2358 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 930.6304 | 23.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 931.4837 | 24.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 931.5543 | 25.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 931.5579 | 25.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 931.6275 | 27.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 933.4956 | 24.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 934.3174 | 2.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 935.0957 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 937.5039 | 24.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 937.9753 | 25.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 939.5217 | 24.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 939.5231 | 24.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 939.5627 | 23.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 939.5676 | 23.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 939.6335 | 27.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 940.6160 | 22.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 941.5316 | 24.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 941.5358 | 24.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 941.5719 | 23.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 941.8490 | 25.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 942.4885 | 22.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 942.4963 | 13.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 943.5331 | 24.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 943.5494 | 25.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 943.5546 | 25.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 944.4765 | 24.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 944.6163 | 26.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 945.4916 | 24.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 945.5491 | 24.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 945.5663 | 25.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 945.5749 | 26.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 945.5751 | 25.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 946.0275 | 25.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 946.5465 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 946.5525 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 946.5808 | 22.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 946.6207 | 23.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 947.5655 | 24.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 949.4682 | 24.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 951.4837 | 24.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 952.6785 | 23.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 955.3802 | 8.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 955.4774 | 24.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 955.6264 | 26.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 955.6271 | 26.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 957.4966 | 24.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 957.5560 | 22.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 958.9595 | 0.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 959.5125 | 24.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 961.5053 | 24.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 962.6319 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 963.5144 | 24.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 963.5148 | 24.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 963.5197 | 24.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 963.5259 | 24.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 963.5292 | 26.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 963.5369 | 25.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 965.5288 | 24.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 966.5993 | 26.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 967.5537 | 25.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 968.5704 | 22.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 968.6701 | 23.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 970.5472 | 22.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 970.5569 | 22.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 970.6374 | 26.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 970.6458 | 27.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 971.4940 | 25.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 971.5006 | 24.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 971.5064 | 24.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 971.5072 | 24.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 971.5146 | 24.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 972.6611 | 28.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 973.5822 | 24.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 974.6551 | 23.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 977.3631 | 8.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 977.4945 | 24.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 978.6196 | 22.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 980.6587 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 981.4825 | 24.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 981.4853 | 24.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 981.6556 | 27.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 982.0162 | 25.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 982.6727 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 982.6731 | 19.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 983.5103 | 24.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 983.5512 | 22.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 983.5748 | 22.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 983.9870 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 985.5004 | 24.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 985.5021 | 24.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 986.5254 | 14.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 986.5278 | 22.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 986.5441 | 22.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 986.5551 | 22.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 987.5361 | 25.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 988.5561 | 22.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 989.5285 | 25.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 989.5289 | 25.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 989.5304 | 25.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 990.0052 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 990.4875 | 24.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 990.6033 | 22.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 990.6490 | 23.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 993.3279 | 8.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 993.7099 | 25.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 994.0197 | 7.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 994.2024 | 25.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 994.5204 | 7.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 994.6333 | 28.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 995.7289 | 26.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 995.7296 | 26.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 996.5013 | 24.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1002.5064 | 10.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1007.3734 | 8.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1012.6053 | 22.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1012.6053 | 22.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1016.9391 | 25.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1018.6804 | 23.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1028.6046 | 22.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1028.6112 | 22.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1028.6144 | 22.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1030.5533 | 14.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1034.6772 | 23.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1046.5929 | 22.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1046.6041 | 22.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1052.6055 | 22.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1052.6162 | 22.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1054.6123 | 22.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1056.6233 | 22.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1056.6273 | 22.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1059.5615 | 8.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1062.7087 | 23.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1066.5813 | 22.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1066.5835 | 22.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1066.6241 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1070.6403 | 23.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1074.5778 | 14.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1075.0440 | 9.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1075.5446 | 9.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1076.6200 | 22.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1078.6980 | 23.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1080.6654 | 22.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1106.7286 | 23.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1112.5696 | 22.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1113.1165 | 10.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1113.6158 | 10.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1122.7238 | 23.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1134.6115 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1144.6687 | 22.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1146.5939 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1146.5940 | 21.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1146.6031 | 22.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1150.7579 | 23.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1153.4300 | 24.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1164.5910 | 22.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1164.5924 | 22.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1164.5941 | 22.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1164.5955 | 22.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1166.7498 | 23.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1166.7590 | 23.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1172.0573 | 1.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1172.3180 | 2.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1174.7288 | 23.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1188.2925 | 2.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1194.7840 | 23.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1210.7736 | 23.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1218.7582 | 23.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1238.8104 | 23.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1254.7905 | 22.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1254.8007 | 23.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1266.7139 | 22.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1270.7145 | 23.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1276.5830 | 10.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1276.5895 | 10.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1282.8326 | 23.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1284.6344 | 8.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1284.7448 | 23.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1298.7487 | 23.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1298.8151 | 22.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1298.8333 | 23.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1306.8083 | 23.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1326.8702 | 23.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1334.6910 | 22.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1338.7156 | 23.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1342.8520 | 23.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1356.5562 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1360.6873 | 23.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1370.8830 | 23.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1380.1368 | 1.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1383.4300 | 25.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1386.9028 | 23.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1414.2000 | 6.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1414.6979 | 6.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1414.9135 | 23.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1430.9222 | 23.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1430.9235 | 22.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1432.7708 | 23.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1443.0724 | 23.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1443.0812 | 24.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1443.0883 | 24.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1458.9438 | 23.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1458.9443 | 23.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1464.0656 | 24.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1467.9656 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1474.9305 | 23.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1484.9976 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1484.9991 | 19.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1492.0872 | 24.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1492.0968 | 24.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1493.0243 | 24.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1493.0390 | 24.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1502.9629 | 23.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1511.0793 | 24.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1521.0818 | 24.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1523.9465 | 22.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1526.0507 | 24.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1526.0558 | 24.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1526.0740 | 23.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1533.0706 | 24.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1533.0789 | 24.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1543.0623 | 24.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1545.0632 | 24.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1545.0728 | 24.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1546.9677 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1553.0656 | 24.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1553.0770 | 24.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1553.9589 | 22.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1555.9691 | 22.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1557.0760 | 24.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1569.0500 | 24.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1569.0752 | 24.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1571.0780 | 24.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1573.0951 | 24.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1577.1356 | 25.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1577.1418 | 25.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1577.1449 | 25.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1577.9365 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1579.0600 | 24.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1579.9698 | 22.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1581.0795 | 24.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1581.0826 | 24.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1583.0860 | 24.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1583.1014 | 24.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1585.1082 | 24.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1585.1093 | 24.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1591.9350 | 22.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1591.9437 | 22.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1595.9330 | 21.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1595.9446 | 22.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1595.9510 | 22.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1597.0969 | 24.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1601.0752 | 24.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1601.9696 | 22.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1621.0496 | 24.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1621.0570 | 24.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1625.9622 | 22.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1633.1031 | 24.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1633.1083 | 24.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1635.1061 | 24.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1639.1505 | 25.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1639.1610 | 25.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1645.0685 | 24.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1647.0707 | 24.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1659.9094 | 22.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1665.9194 | 22.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1665.9355 | 22.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1669.0420 | 24.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1669.9496 | 22.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1669.9600 | 22.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1677.1261 | 25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1687.1564 | 24.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1687.1567 | 25.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1687.1594 | 25.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1689.0394 | 24.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1689.0486 | 24.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1689.0966 | 22.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1689.0995 | 23.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1705.0302 | 24.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1709.0277 | 24.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1713.0521 | 24.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1713.0634 | 24.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1727.9164 | 22.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1733.9312 | 22.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1733.9443 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1737.0530 | 24.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1745.1058 | 25.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1751.0315 | 24.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1757.0403 | 24.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1761.0667 | 24.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1761.0845 | 24.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1785.0393 | 24.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1785.0635 | 24.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1789.0532 | 24.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1789.0638 | 24.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1789.0833 | 24.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1793.1053 | 25.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1805.0230 | 24.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1805.0320 | 24.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1805.0485 | 24.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1813.1097 | 25.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1813.1102 | 25.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1819.0130 | 24.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1825.0243 | 24.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1825.0280 | 24.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1861.0929 | 25.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1861.1038 | 25.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1867.0139 | 24.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1873.0142 | 24.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1875.0594 | 25.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1875.0753 | 25.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1881.1060 | 25.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1893.0132 | 24.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1943.1007 | 25.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1952.8698 | 22.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1954.9830 | 24.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1960.9938 | 24.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | GALACTITOL OR DULCITOL (CAS# 608-66-2); (M+H)+ | 0.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | SELENOCYSTAMINE (CAS# 2697-61-2); (M+H)+ | 0.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | (S)-2-AMINO-3-(3-HYDOXY-4-OXO-4H-PYRIDIN-1-YL)PROPANOATE OR L-MIMOSINE (CAS# 500-44-7); (M+H)+ | 0.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | GDPMANNOSE (CAS# ); (M+NA)+ | 0.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | GDPMANNOSE (CAS# ); (M+H)+ | 0.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | ADENOSINE 5'-PHOSPHOSULFATE (CAS# 485-84-7); (M+NA)+ | 1.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | URACIL 5-CARBOXYLATE (CAS# 23945-44-0); (M+H)+ | 1.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 2'-DEOXYINOSINE (CAS# 890-38-0); (2M+H)+ | 2.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 2'-DEOXYINOSINE (CAS# 890-38-0); (M+NA)+ | 2.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 2'-DEOXYINOSINE (CAS# 890-38-0); (M+H)+ | 2.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 1-PHENYLETHANOL (CAS# 1445-91-6); (M+H)+[-H2O] | 2.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | ABRINE (CAS# 526-31-8); (M+H)+ | 3.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 5-METHYLTETRAHYDROFOLATE (CAS# 134-35-0); (M+H)+ | 3.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | ZEATIN [ISTD] (CAS# 13114-27-7); (M+H)+ | 3.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | 4-HYDROXY-2-QUINOLINECARBOXYLIC ACID-KRYNURENIC ACID (CAS# 492-27-3); (M+H)+ | 4.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | N-ACETYL-L-LEUCINE (CAS# 1188-21-2); (M+NA)+ | 7.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001156 | CALCIDIOL (CAS# 19356-17-3); (M+NA)+ | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |